OMEPRAZOLE\SODIUM BICARBONATE: 1,937 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
1,937
Total FAERS Reports
128 (6.6%)
Deaths Reported
165
Hospitalizations
1,937
As Primary/Secondary Suspect
6
Life-Threatening
20
Disabilities
First Report: 1994 · Latest Report: 20250630
What Are the Most Common OMEPRAZOLE\SODIUM BICARBONATE Side Effects?
#1 Most Reported
Chronic kidney disease
1,005 reports (51.9%)
#2 Most Reported
Acute kidney injury
564 reports (29.1%)
#3 Most Reported
Renal failure
528 reports (27.3%)
All OMEPRAZOLE\SODIUM BICARBONATE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Chronic kidney disease | 1,005 | 51.9% | 98 | 144 |
| Acute kidney injury | 564 | 29.1% | 66 | 113 |
| Renal failure | 528 | 27.3% | 84 | 113 |
| Renal injury | 282 | 14.6% | 30 | 45 |
| End stage renal disease | 275 | 14.2% | 63 | 72 |
| Product use issue | 210 | 10.8% | 0 | 1 |
| Drug ineffective | 146 | 7.5% | 1 | 1 |
| Tubulointerstitial nephritis | 133 | 6.9% | 11 | 26 |
| Gastrooesophageal reflux disease | 126 | 6.5% | 3 | 13 |
| Rebound acid hypersecretion | 95 | 4.9% | 12 | 14 |
| Nephrogenic anaemia | 94 | 4.9% | 16 | 33 |
| Off label use | 84 | 4.3% | 0 | 0 |
| Renal impairment | 64 | 3.3% | 10 | 12 |
| Nephropathy | 63 | 3.3% | 15 | 18 |
| Incorrect product administration duration | 52 | 2.7% | 0 | 0 |
| Hyperparathyroidism secondary | 48 | 2.5% | 8 | 15 |
| Death | 46 | 2.4% | 46 | 5 |
| Nausea | 40 | 2.1% | 1 | 2 |
| Product use in unapproved indication | 38 | 2.0% | 0 | 0 |
| Product prescribing issue | 37 | 1.9% | 0 | 0 |
Who Reports OMEPRAZOLE\SODIUM BICARBONATE Side Effects? Age & Gender Data
Gender: 61.3% female, 38.7% male. Average age: 57.3 years. Most reports from: US. View detailed demographics →
Is OMEPRAZOLE\SODIUM BICARBONATE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2000 | 10 | 4 | 0 |
| 2001 | 1 | 0 | 0 |
| 2003 | 15 | 2 | 0 |
| 2004 | 4 | 1 | 1 |
| 2005 | 16 | 2 | 4 |
| 2006 | 15 | 4 | 3 |
| 2007 | 31 | 4 | 10 |
| 2008 | 27 | 3 | 7 |
| 2009 | 35 | 3 | 6 |
| 2010 | 43 | 4 | 4 |
| 2011 | 51 | 3 | 11 |
| 2012 | 93 | 6 | 16 |
| 2013 | 90 | 11 | 17 |
| 2014 | 120 | 8 | 18 |
| 2015 | 131 | 8 | 15 |
| 2016 | 154 | 5 | 15 |
| 2017 | 132 | 5 | 8 |
| 2018 | 73 | 0 | 1 |
| 2019 | 42 | 1 | 0 |
| 2020 | 14 | 2 | 0 |
| 2021 | 23 | 0 | 0 |
| 2022 | 12 | 0 | 0 |
| 2023 | 13 | 0 | 1 |
| 2024 | 14 | 0 | 0 |
| 2025 | 4 | 0 | 1 |
What Is OMEPRAZOLE\SODIUM BICARBONATE Used For?
| Indication | Reports |
|---|---|
| Gastrooesophageal reflux disease | 762 |
| Product used for unknown indication | 311 |
| Dyspepsia | 207 |
| Gastrointestinal disorder | 119 |
| Gastric ph decreased | 21 |
| Gastritis | 12 |
| Abdominal pain upper | 11 |
| Barrett's oesophagus | 8 |
| Prophylaxis | 8 |
| Ulcer | 8 |
OMEPRAZOLE\SODIUM BICARBONATE vs Alternatives: Which Is Safer?
OMEPRAZOLE\SODIUM BICARBONATE vs OMNIPAQUE
OMEPRAZOLE\SODIUM BICARBONATE vs OMNISCAN
OMEPRAZOLE\SODIUM BICARBONATE vs ONABOTULINUMTOXINA
OMEPRAZOLE\SODIUM BICARBONATE vs ONASEMNOGENE ABEPARVOVEC
OMEPRAZOLE\SODIUM BICARBONATE vs ONASEMNOGENE ABEPARVOVEC-XIOI
OMEPRAZOLE\SODIUM BICARBONATE vs ONBREZ
OMEPRAZOLE\SODIUM BICARBONATE vs ONDANSETRON
OMEPRAZOLE\SODIUM BICARBONATE vs ONFI
OMEPRAZOLE\SODIUM BICARBONATE vs OPANA
OMEPRAZOLE\SODIUM BICARBONATE vs OPICAPONE
Official FDA Label for OMEPRAZOLE\SODIUM BICARBONATE
Official prescribing information from the FDA-approved drug label.